Dogecoin (DOGE) remains one of the most closely watched cryptocurrencies, known for its volatility and popularity among ...

Bitcoin price successfully closes above the $66,000 resistance level, eyeing a rally ahead. Ethereum price bounces off its ...

In line with our expectations, during the first half of last week ... While, on the upside, the 50-day EMA (Exponential ...

Aptos (APT) surged 24%, but mixed technical signals raise concerns about sustaining the rally, with weakening bullish momentum.

The moving average convergence or divergence (MACD) helps traders decide when to buy or sell stock based on its recent price action.

EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...

UK Retail Sales bounced 0.3% in September, falling back from August’s 1.0% but still sticking well above the expected -0.3% ...

BAYRY submits an application seeking EMA approval of elinzanetant for treating hot flashes associated with menopause or ...

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment ...

For immediate release Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia ...

On Friday, Novartis AG (NYSE:NVS) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...